Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD

Bone Marrow Transplantation

Volumn 42, Issue 8, 2008, Pages 541-546

  Andree, H ^a   Hilgendorf, I ^a   Leithaeuser, M ^a   Junghanss, C ^a   Holzhueter, S ^a   Loddenkemper, C ^b   Steiner, B ^a   Freund, M ^a   Wolff, D ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTIBIOTIC AGENT; ATOVAQUONE; BUDENOFALK; BUDESONIDE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DACLIZUMAB; ETANERCEPT; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TREOSULFAN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; DIARRHEA; DONOR LYMPHOCYTE INFUSION; DOSE RESPONSE; DRUG EFFICACY; DRUG OVERDOSE; EOSINOPHILIA; FEMALE; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; HYPERPIGMENTATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MONOTHERAPY; MULTIPLE MYELOMA; MYELOABLATIVE CONDITIONING; NAUSEA; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIC PURPURA; UNSPECIFIED SIDE EFFECT; WHOLE BODY RADIATION;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS;

EID: 55549131890     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.209     Document Type: Article

References (18)

1. Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: Association with treatment-related mortality and relapse. Blood 2002; 100: 406-414.
2. Jacobsohn DA, Margolis J, Doherty J, Anders V, Vogelsang GB. Weight loss and malnutrition in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2002; 29: 231-236.
3. Patey-Mariaud dS, Reijasse D, Verkarre V, Canioni D, Colomb V, Haddad E et al. Chronic intestinal graft-versus-host disease: Clinical, histological and immunohistochemical analysis of 17 children. Bone Marrow Transplant 2002; 29: 223-230.
4. Sale GE, Shulman HM, McDonald GB, Thomas ED. Gastrointestinal graft-versus-host disease in man. A clinico-pathologic study of the rectal biopsy. Am J Surg Pathol 1979; 3: 291-299.
5. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
6. Snover DC, Weisdorf SA, Vercellotti GM, Rank B, Hutton S, McGlave P. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation. Hum Pathol 1985; 16: 387-392.
7. Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E et al Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease - II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006; 12: 31-47.
8. Vogelsang GB, Wolff D, Altomonte V, Farmer E, Morison WL, Corio R et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant 1996; 17: 1061-1067.
9. Wolff D, Anders V, Corio R, Horn T, Morison WL, Farmer E et al. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs-host disease. Photodermatol Photoimmunol Photomed 2004; 20: 184-190.
10. Bertz H, Afting M, Kreisel W, Duffner U, Greinwald R, Finke J. Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD. Bone Marrow Transplant 1999; 24: 1185-1189.
11. Elad S, Or R, Garfunkel AA, Shapira MY. Budesonide: A novel treatment for oral chronic graft versus host disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 308-311.
12. McDonald GB, Bouvier M, Hockenbery DM, Stern JM, Gooley T, Farrand A et al. Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: A randomized, controlled trial. Gastroenterology 1998; 115: 28-35.
13. Hockenbery DM, Cruickshank S, Rodell TC, Gooley T, Schuening F, Rowley S et al. A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. Blood 2007; 109: 4557-4563.
14. Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U et al. Treosulfan and fludarabine: A new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 2004; 103: 725-731.
15. Schmid C, Schleuning M, Hentrich M, Markl GE, Gerbitz A, Tischer J et al. High antileukemic efficacy of an intermediate intensity conditioning regimen for allogeneic stem cell transplantation in patients with high-risk acute myeloid leukemia in first complete remission. Bone Marrow Transplant 2008; 41: 721-727.
16. Wolff D, Roessler V, Steiner B, Wilhelm S, Weirich V, Brenmoehl J et al. Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. Bone Marrow Transplant 2005; 35 1003-1010.
17. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
18. Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA et al Therapy for chronic graft-versus-host disease: A randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 2002; 100: 48-51.